Chinese vaccines gaining popularity abroad
February 6, 2017 Category Health, Weekly
Seth Berkley, CEO of the Global Alliance for Vaccines and Immunization, said Chinese vaccines are “significantly cheaper” than those made by many other countries. The Chinese-made vaccine for Japanese encephalitis, for example, is up to 95% less expensive than those produced in the West, he said. With an average price of USD0.42 a dose, the live attenuated vaccine made by the Chengdu Institute of Biological Products is providing lifesaving protection to millions of children in low-income countries, including Laos, Nepal and Cambodia, under the Alliance’s program, which has committed to using 27.7 million doses of the vaccine. Berkley hailed China’s efforts to move on from being an alliance recipient of vaccines to being a key supplier. China’s Japanese encephalitis vaccine became available on the global market after the World Health Organization (WHO) endorsed China’s vaccine regulatory body in 2011. Two years later, the product became the first prequalified Chinese vaccine to be licensed for use on children, the China Daily reports.
- KURT VANDEPUTTE (UMICORE) APPOINTED CHAIRMAN OF THE BOARD OF THE FLANDERS-CHINA CHAMBER OF COMMERCE (FCCC)
- Webinar: “Knowing Your Chinese Partner” – May 26, 2021, 10 am – 12 am
- EMA starts rolling review of CoronaVac, WHO approves Sinopharm vaccine for emergency use
- The Global Times warns not to politicize the Comprehensive Agreement on Investment (CAI)
- Hainan to become biggest duty-free market in the world